ArticleJournal of the National Cancer Institute2020
RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.
Federica Tomao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.